Longboard Pharmaceuticals, Inc. - Common Stock (NQ:LBPH)

59.98 UNCHANGED

Last Price Updated: 1:00 PM EST, Nov 29, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Longboard Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >

Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt ↗

December 07, 2024

Dental supply maker Patterson Companies Inc announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value.

Via Benzinga

Topics Supply Chain

Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags ↗

October 21, 2024

S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day.

Via Benzinga

Topics Bankruptcy Stocks

Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio? ↗

October 20, 2024

These seven mid-cap stocks were the best performers in the last week. Are they in your portfolio?

Via Benzinga

Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump ↗

October 14, 2024

Via Benzinga

Topics Stocks

Recap: Longboard Pharmaceuticals Q4 Earnings ↗

March 12, 2024

Via Benzinga

Looking Into Longboard Pharmaceuticals's Recent Short Interest ↗

January 19, 2024

Via Benzinga

NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday ↗

October 14, 2024

Via Benzinga

Topics Government

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 14, 2024

Via Benzinga

Top 1% Biotech Longboard Scores A $2.6 Billion Deal And Skyrockets To A Record ↗

October 14, 2024

Lundbeck will buy Longboard Pharmaceuticals in a deal slated to close in the fourth quarter.

Via Investor's Business Daily

Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday? ↗

October 14, 2024

H. Lundbeck acquires Longboard Pharmaceuticals for $2.6 billion. The acquisition strengthens Lundbeck's pipeline with bexicaserin, a potential treatment for Dravet syndrome and other neurological...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 14, 2024

Via Benzinga

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket ↗

October 14, 2024

Via Benzinga

Starbucks To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

September 18, 2024

Via Benzinga

Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage ↗

September 10, 2024

Truist Securities initiated coverage on Longboard Pharmaceuticals, citing it as a CNS-focused biotech with high-value epilepsy assets.

Via Benzinga

3 Russell 2000 Growth Stocks That Could Be Worth the Risk ↗

July 23, 2024

These three small-cap stocks could deliver hefty returns if the central bank cuts rates.

Via The Motley Fool

Topics Economy

Top 3 Health Care Stocks That May Crash This Quarter ↗

July 03, 2024

Via Benzinga

LBPH Stock Earnings: Longboard Pharmaceuticals Beats EPS for Q1 2024 ↗

May 02, 2024

LBPH stock results show that Longboard Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 26, 2024

Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.

Via Benzinga

Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher ↗

January 17, 2024

You might say that this biotech stock is magnificent.

Via The Motley Fool

Cantor Fitzgerald Maintains Overweight Rating for Longboard Pharmaceuticals: Here's What You Need To Know ↗

January 16, 2024

Via Benzinga

Jim Cramer: This Energy Firm Has 'Good Growth, Good Yield' But As For IonQ? Ixnay ↗

January 04, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Equitrans Midstream Corporation (NYSE: ETRN) is very solid. "Good growth, good yield.

Via Benzinga

Why Longboard Pharmaceuticals Stock Is Falling ↗

January 03, 2024

Longboard Pharmaceuticals Inc (NASDAQ: LBPH) shares are trading lower by 11.3% to $22.26 Wednesday afternoon after the company announced that it commenced a $150 million underwritten public offering...

Via Benzinga

Apple, Longboard Pharmaceuticals, Coinbase, Moderna, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

January 02, 2024

U.S. stocks experienced mixed results in Tuesday’s trading session. The Dow Jones index showed resilience, gaining around 25 points, a modest rise of 0.07% to 37,715.04. In contrast, the tech-heavy...

Via Benzinga

Topics Stocks

Why Longboard Pharma Catapulted 316%, Leading A Biotech Stock Rally ↗

January 02, 2024

Longboard Pharmaceuticals is working on treatments for seizure disorders.

Via Investor's Business Daily

Crude Oil Down 2%; Tesla Deliveries Top Estimates ↗

January 02, 2024

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling more than 250 points on Tuesday. The Dow traded up 0.01% to 37,691.77 while the NASDAQ fell 1.78% to...

Via Benzinga

Topics Stocks

There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target ↗

January 02, 2024

Tuesday, Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of...

Via Benzinga

Why Is Longboard Pharmaceuticals (LBPH) Stock Up 175% Today? ↗

January 02, 2024

With Longboard Pharmaceuticals delivering positive clinical trial data, LBPH stock soared on the positive therapeutic implications.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 02, 2024

Via Benzinga

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 02, 2024

Shares of Longboard Pharmaceuticals, Inc.

Via Benzinga

Dow Turns Higher; Anavex Life Sciences Shares Plunge ↗

January 02, 2024

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.13% to 37,739.18 while the NASDAQ fell 1.29% to 14,818.23. The S&P 500...

Via Benzinga

Topics Stocks

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.